Clinical Trial

Characterization of Potential Biomarkers of Eye Disease and Vision

Study acronym: EYE-MARKER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2015-07-15; most recent amendment 2024-07-29.
Status change: Recruiting → Active, Not Recruiting 2024-07-29
Status change: Active, Not Recruiting → Recruiting 2023-07-17
Status change: Recruiting → Active, Not Recruiting 2016-04-22
Status change: Not Yet Recruiting → Recruiting 2015-10-19
Trial Details
NCT Number NCT02500862
Lead Sponsor Association for Innovation and Biomedical Research on Light and Image
Conditions Eye Disease
Enrollment 100 participants
Start Date 2015-09
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-30